MindMaze Therapeutics develops scalable digital neurotherapeutics for neurological conditions, combining software-delivered behavioral treatments, proprietary sensors and devices, and AI-driven analytics
MindMaze Therapeutics develops scalable digital neurotherapeutics for neurological conditions, combining software-delivered behavioral treatments, proprietary sensors and devices, and AI-driven analytics. Its assessment and rehabilitation solutions support motor and cognitive recovery across hospital, outpatient, and home settings, including for stroke, Parkinson’s disease, and other neurological disorders.